Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.44B | 34.47B | 31.12B | 29.00B | 28.48B | 27.46B |
Gross Profit | 5.59B | 4.50B | 753.00M | 3.42B | 3.42B | 2.14B |
EBITDA | 2.99B | 3.67B | -1.58B | 1.18B | 1.12B | 92.00M |
Net Income | 198.00M | 1.18B | -4.53B | -467.00M | -453.00M | -1.61B |
Balance Sheet | ||||||
Total Assets | 48.52B | 50.87B | 47.91B | 51.17B | 44.14B | 43.03B |
Cash, Cash Equivalents and Short-Term Investments | 5.29B | 7.25B | 4.59B | 8.52B | 5.92B | 5.18B |
Total Debt | 3.85B | 3.77B | 4.78B | 3.22B | 2.73B | 2.39B |
Total Liabilities | 38.50B | 41.51B | 39.12B | 33.99B | 28.92B | 27.64B |
Stockholders Equity | 9.73B | 9.07B | 8.50B | 17.19B | 14.96B | 14.94B |
Cash Flow | ||||||
Free Cash Flow | 3.93B | 1.38B | 394.00M | 1.06B | 959.00M | 674.00M |
Operating Cash Flow | 5.48B | 2.89B | 1.62B | 2.22B | 1.95B | 1.60B |
Investing Cash Flow | -1.52B | 1.25B | -1.63B | -1.12B | -958.00M | -1.04B |
Financing Cash Flow | -972.00M | -2.26B | -1.13B | -568.00M | -340.00M | 2.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $12.07B | 24.40 | 19.27% | 0.91% | 6.99% | 23.25% | |
79 Outperform | $24.34B | 10.69 | 17.45% | 1.14% | -5.86% | 59.79% | |
76 Outperform | $86.06B | 25.99 | 27.16% | 1.07% | -0.23% | 22.41% | |
73 Outperform | $72.81B | 31.20 | 9.82% | 1.61% | 6.49% | 24.14% | |
69 Neutral | $13.18B | 27.70 | 12.73% | 1.62% | 1.66% | -17.18% | |
68 Neutral | $83.72B | 392.78 | 1.79% | ― | 16.00% | ― | |
68 Neutral | £2.90B | 10.30 | 8.40% | 3.33% | 2.88% | -10.00% |